Stock listing

KRX:145020 Hugel, Inc. (휴젤) 주가

Follow Hugel, Inc. into a list and get an email when it puts out news.

Share price · KRX:145020

₩206,500 KRW +8,000 (+4.0%)

Close on Nov 20, 2026

Past year -11.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩204,500 – ₩214,500 KRWNov 20, 2026
Volume
75,242 sharesNov 20, 2026
Market cap
₩2.23T KRWAt the close on Nov 20, 2026 · price × 10.80M shares outstanding
52-week range
₩163,700 – ₩308,500 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩10.33B KRWMedian day 42,829 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Hugel, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:145020 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩206,500+8,000+4.0%₩210,000₩214,500₩204,50075,242
₩198,500+5,900+3.1%₩192,500₩202,000₩192,50074,320
₩192,600+200+0.1%₩191,700₩195,200₩190,40059,282
₩192,400+100+0.1%₩193,100₩194,900₩187,60043,313
₩192,300-4,100-2.1%₩196,500₩202,000₩191,50042,876
₩196,400+900+0.5%₩194,100₩199,700₩190,60060,029
₩195,500-3,800-1.9%₩198,900₩201,000₩192,80054,775
₩199,300+12,200+6.5%₩189,500₩201,500₩188,20064,770
₩187,100-400-0.2%₩186,600₩190,900₩179,50044,631
₩187,50000.0%₩181,000₩193,000₩178,400102,777
₩187,500+3,500+1.9%₩186,100₩194,500₩186,10084,943
₩184,000-5,500-2.9%₩189,600₩191,000₩167,400120,209
₩189,500+6,500+3.6%₩181,200₩191,700₩180,60062,830
₩183,000+3,200+1.8%₩179,800₩183,900₩178,30030,816
₩179,800-3,500-1.9%₩182,400₩183,000₩177,00035,682
₩183,300+1,800+1.0%₩183,200₩183,600₩178,00042,782
₩181,500+2,100+1.2%₩179,400₩183,000₩179,40025,862
₩179,400+3,000+1.7%₩178,100₩184,900₩177,30040,313
₩176,400-3,700-2.1%₩177,000₩180,800₩175,90024,338
₩180,100-700-0.4%₩180,500₩182,000₩176,60058,676
₩180,800-5,000-2.7%₩186,300₩186,400₩180,30043,616
₩185,800+1,600+0.9%₩184,600₩188,900₩184,60036,635
₩184,200-2,800-1.5%₩184,500₩190,100₩182,80049,794
₩187,000+7,900+4.4%₩179,800₩187,000₩177,00040,163
₩179,100+10,600+6.3%₩168,700₩182,000₩168,70066,506
₩168,500-4,000-2.3%₩167,500₩170,900₩163,70043,550
₩172,500+2,600+1.5%₩171,300₩177,000₩171,00046,666
₩169,900-10,100-5.6%₩179,100₩179,300₩164,10068,154
₩180,000-2,800-1.5%₩181,900₩182,400₩179,40064,190
₩182,800-800-0.4%₩183,900₩184,400₩179,40054,306
₩183,600+2,100+1.2%₩182,400₩186,100₩182,20032,479
₩181,500+1,400+0.8%₩180,100₩182,900₩178,90057,448
₩180,100-500-0.3%₩180,600₩183,700₩179,40039,279
₩180,600+900+0.5%₩178,200₩181,000₩175,50065,544
₩179,700-3,600-2.0%₩184,400₩185,500₩178,70047,092
₩183,300-2,800-1.5%₩180,900₩189,000₩178,600102,069
₩186,100-900-0.5%₩187,700₩190,800₩182,30085,822
₩187,000-3,400-1.8%₩189,900₩191,300₩185,90042,222
₩190,400-15,600-7.6%₩205,000₩205,500₩188,200204,511
₩206,000-8,000-3.7%₩212,500₩213,500₩205,00077,391
₩214,000-17,500-7.6%₩232,000₩233,500₩212,500164,420
₩231,500+500+0.2%₩231,500₩232,000₩228,00029,436
₩231,000-4,500-1.9%₩232,500₩234,500₩227,50028,519
₩235,500+3,500+1.5%₩229,500₩238,500₩229,50037,807
₩232,000+1,000+0.4%₩228,500₩234,500₩225,50031,158
₩231,000-5,000-2.1%₩229,500₩235,000₩229,00032,932
₩236,00000.0%₩235,000₩236,000₩227,50041,740
₩236,000-2,000-0.8%₩236,500₩238,500₩234,50024,658
₩238,000-5,000-2.1%₩243,500₩244,500₩237,50022,715
₩243,000-1,000-0.4%₩245,000₩245,000₩241,00011,435
₩244,000+3,500+1.5%₩243,000₩245,000₩240,50027,884
₩240,500-5,000-2.0%₩247,500₩251,000₩239,00030,768
₩245,500+500+0.2%₩242,000₩251,500₩237,00035,698
₩245,000-7,000-2.8%₩249,500₩250,500₩242,50024,852
₩252,000-7,000-2.7%₩257,000₩257,000₩246,00039,313
₩259,000+13,500+5.5%₩244,500₩262,000₩244,50054,163
₩245,500-5,000-2.0%₩247,500₩252,000₩244,50020,894
₩250,500+2,000+0.8%₩245,500₩252,500₩245,50021,741
₩248,500-2,000-0.8%₩248,500₩251,000₩241,25019,862
₩250,500+5,500+2.2%₩243,000₩256,000₩243,00037,596
₩245,000-4,000-1.6%₩243,000₩247,000₩238,00027,715
₩249,000+2,000+0.8%₩249,000₩251,500₩243,00034,361

Splits

1 split · KRX:145020 · every price before a split is adjusted for it

DayRatioWhat
3-for-1Split
Ticker
KRX:145020
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Hugel, Inc. news

Hugel, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
2 in the last 12 months · 9 in all · newest May 7, 2026 · oldest 2025
Decks
2 decks · latest Jan 15, 2026

Valuation

P/E 14.1× against a median of 18.1×: 5th lowest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩1.62T KRW
P/E
14.1×
EV/sales
3.4×
EV/EBITDA
7.1×
Price/book
2.1×
Gross margin
77.9%
Operating margin
43.6%
Net margin
32.9%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hugel, Inc. · KRX:145020US$1.66BUS$1.21B14.1×3.4×7.1×2.1×32.9%0.0×n/a
Ultragenyx Pharmaceutical Inc. · NASDAQ:RAREUS$1.68BUS$2.60Bn/a3.6×n/an/a−71.8%n/a1.35
Supernus Pharmaceuticals, Inc. · NASDAQ:SUPNUS$1.67BUS$1.85B3.7×1.4×n/an/a32.9%n/a0.67
Caplin Point Laboratories Limited · NSE:CAPLIPOINTUS$1.66BUS$1.56B23.2×6.3×18.1×4.3×29.1%0.0×n/a
AstraZeneca Pharma India Limited · NSE:ASTRAZENUS$1.66BUS$1.60B86.8×5.7×59.3×17.5×6.8%0.0×n/a
Agios Pharmaceuticals, Inc. · NASDAQ:AGIOUS$1.65BUS$1.05Bn/a7.4×n/a1.7×−264.8%0.0×1.10
Faes Farma, S.A. · BME:FAEUS$1.65BUS$1.93B11.0×1.7×5.8×1.9×13.1%0.5×n/a
Consun Pharmaceutical Group Ltd. · HKEX:1681US$1.64BUS$1.06B10.1×2.1×5.6×2.3×31.6%0.1×n/a
BrightGene Bio-Medical Technology Co. Ltd. Class A · SSE:688166US$1.63BUS$1.68B106×8.3×n/a3.5×7.6%0.5×n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A · SZSE:002399US$1.62BUS$986.2M57.0×1.3×n/a0.9×3.7%0.0×n/a
NATCO Pharma Limited · NSE:NATCOPHARMUS$1.62BUS$1.62B13.1×4.3×14.2×1.6×32.8%0.0×n/a
Median of the othersUS$1.65BUS$1.61B18.1×3.9×14.2×2.1×10.3%0.0×1.10

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
281777.78 KRW · Analysts' mean
EPS, year to Dec 2026
10467.85 · 12 analysts
Revenue, year to Dec 2026
494.3B · 15 analysts

Team and board

OfficerRole
Carrie StromChief Executive Officer

Events

Next results
Feb 10, 2027 (expected)
QuarterResultsShare move
Quarter to Sep 30, 2026Nov 12, 2026 · After close−2.1%
Q2 2026Aug 14, 2026−5.5%
Q1 2026May 7, 2026 · Before open+1.8%
Q4 2025Mar 19, 2026 · Before open−2.8%
Q3 2025Nov 14, 2025 · Before open0.0%
Q2 2025Aug 14, 2025 · Before open−0.3%
Q1 2025May 8, 2025 · Before open+2.4%
Q4 2024Mar 21, 2025 · Before open+1.2%
Q3 2024Nov 14, 2024 · Before open+3.8%
Q2 2024Aug 14, 2024+5.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−4.5%
Q4 2023Mar 21, 2024 · Before open−2.3%
Q3 2023Nov 14, 2023 · Before open+3.6%
Q2 2023Aug 11, 2023 · Before open−2.1%
Q1 2023May 15, 2023 · Before open−1.1%
Q4 2022Feb 9, 2023 · Before open+3.9%
Q3 2022Nov 14, 2022 · Before open−3.6%
Q2 2022Aug 16, 2022 · Before open−4.8%
Q1 2022May 16, 2022 · Before open−2.1%
Q4 2021Mar 17, 2022 · Before open+5.4%

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2026Conference19 slidesJan 15, 2026
J.P. Morgan Healthcare Conference 2025Conference37 slidesJanuary 2025

Open Decks

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue425.1B373.0B319.7B281.7B245.2B211.0B204.6B182.4B182.1B124.2B
Cost of revenue91.6B85.9B73.5B62.8B64.4B62.3B60.6B51.0B40.0B29.8B
Gross profit333.5B287.2B246.2B218.9B180.8B148.8B143.9B131.4B142.1B94.4B
Research and development11.7B9.21B11.0B15.1B12.6B15.7B7.75B6.92B4.06B
Selling, general and administrative63.9B102.7B109.4B94.5B63.2B49.8B61.6B61.0B31.0B25.3B
Operating income200.9B147.8B106.2B94.5B96.2B77.4B68.1B85.6B102.4B63.2B
Depreciation and amortization19.7B10.5B13.9B14.0B14.3B10.7B9.49B7.49B6.76B3.92B
EBITDA220.6B158.3B120.1B108.5B110.5B88.1B77.6B93.1B109.1B67.2B
Interest expense1.13B1.18B2.94B3.11B3.72B3.66B0000
Income before tax196.8B165.2B133.3B73.1B89.0B69.3B69.7B99.5B103.5B64.3B
Income tax9.18B28.3B24.0B19.4B23.9B22.2B13.4B
Net income140.9B135.8B93.1B57.3B57.7B42.0B44.6B69.7B72.8B43.3B
Earnings per share, basic13,039.7112,347.568,299.884,856.264,744.193,352.513,561.655,496.315,641.364,418.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents209.7B130.1B106.0B2.46M294.1B62.4B15.2B29.0B31.3B64.9B
Short-term investments329.1B293.0B375.9B392.2B258.0B536.8B553.6B572.6B564.4B39.3B
Receivables75.0B48.4B44.1B53.2B28.4B28.0B38.3B56.1B66.3B32.3B
Inventory55.8B42.6B34.3B26.9B27.4B23.2B28.9B21.9B15.5B13.5B
Current assets679.4B522.9B567.8B617.9B616.1B668.4B640.9B684.8B679.4B151.3B
Property, plant and equipment151.0B134.7B120.5B95.7B76.9B69.8B60.6B59.0B58.8B
Goodwill78.1B86.2B83.3B84.6B95.4B92.5B76.2B75.5B55.1B55.1B
Total assets1.08T939.4B929.3B1.05T1.01T956.3B894.7B918.3B820.9B294.3B
Accounts payable5.99B4.35B2.95B4.81B6.86B4.78B5.69B6.06B4.72B3.24B
Current liabilities93.0B61.1B57.4B177.3B54.0B43.8B37.6B23.0B22.7B19.9B
Long-term debt24.5B88.8B093.9B90.1B86.4B82.9B79.6B0
Total debt92.3B90.2B82.9B79.6B
Total liabilities96.7B98.6B149.6B257.7B232.7B209.7B195.2B190.5B125.2B41.5B
Shareholders' equity950.3B803.8B747.3B792.1B777.1B746.7B699.5B727.7B695.7B252.8B
Shares outstanding10.8M11.0M11.2M11.8M12.2M12.5M12.5M12.7M12.9M9.79M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations150.1B149.1B117.7B80.6B85.9B74.3B77.0B65.8B64.2B45.1B
Capital spending-29.5B-33.3B-40.6B-32.8B-23.9B-17.0B-12.3B-9.10B-6.34B-16.1B
Free cash flow120.5B115.7B77.2B35.6B37.5B29.1B64.7B56.7B57.8B29.0B
Cash from investing42.4B43.2B-191.8B180.1B-25.3B-979.3M-32.2B-555.3B-53.9B
Cash from financing-172.1B-187.1B-51.4B-36.0B-1.84B-90.3B-35.6B457.6B3.13B
Dividends paid0-105.9M
Share buybacks-1.32B-166.3B-122.4B-44.5B-34.6B-46.2B-35.6B357.9B4.23B
Change in cash79.6B24.1B-25.8B-162.4B231.8B47.1B-13.7B-2.27B-33.6B-5.63B

Open Financials

Cap table

Built by 6ix from Hugel, Inc.’s releases

Common shares
10,803,292
Fully diluted
10,803,292

Fully diluted

LineShares
Common shares10,803,292

Share count over time

CountShares
Nov 22, 202610,803,292

Open Cap table

Shareholders

HolderSharesValueAs of
MFS International New Discovery Fund436KUS$74.6MJun 30, 2026
MFS Emerging Markets Equity Fund173KUS$28.5MMay 31, 2026
Matthews Emerging Markets Small Companies Fund86,081US$14.8MJun 30, 2026
Vanguard Total International Stock Index Fund81,344US$13.1MJul 31, 2026
iShares Core MSCI Emerging Markets ETF67,298US$11.1MMay 31, 2026
Vanguard Developed Markets Index Fund53,572US$9.18MJun 30, 2026
Templeton Emerging Markets Small Cap Fund47,592US$7.84MMay 31, 2026
BNY Mellon Global Emerging Markets Fund32,565US$5.32MJul 31, 2026
Transamerica Emerging Markets Equity25,920US$4.18MJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund23,810US$3.84MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Emerging Markets Core Equity 2 Portfolio21,517US$3.47MJul 31, 2026
Dimensional Emerging Markets Value Fund17,191US$2.77MJul 31, 2026
BNY Mellon Emerging Markets Fund17,017US$2.81MMay 31, 2026
Schwab International Small-Cap Equity ETF11,378US$1.88MMay 31, 2026
JPMorgan Emerging Markets Research Enhanced Equity Fund11,075US$1.79MJul 31, 2026
Avantis Emerging Markets Equity ETF10,685US$1.76MMay 31, 2026
iShares Core MSCI Total International Stock ETF9,061US$1.46MJul 31, 2026
The Emerging Markets Small Cap Series8,165US$1.32MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF7,717US$1.31MJun 30, 2026
Dimensional Emerging Markets Core Equity 2 ETF7,353US$1.2MJul 31, 2026
Vanguard Pacific Stock Index Fund6,160US$993KJul 31, 2026
JPMorgan ActiveBuilders Emerging Markets Equity ETF5,741US$926KJul 31, 2026
Vanguard Total World Stock Index Fund4,981US$803KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account4,291US$735KJun 30, 2026
Dimensional World ex. U.S. Core Equity 2 ETF4,198US$685KJul 31, 2026
Matthews Emerging Markets Discovery Active ETF4,164US$710KJun 30, 2026
Schwab Health Care Fund3,776US$609KJul 31, 2026
Dimensional Emerging Core Equity Market ETF3,733US$609KJul 31, 2026
Fidelity Total International Index Fund3,217US$513KJul 31, 2026
Dimensional Emerging Markets Value ETF2,975US$485KJul 31, 2026
Emerging Economies Fund2,503US$413KMay 31, 2026
The Emerging Markets Series2,176US$351KJul 31, 2026
Matthews Emerging Markets ex China Active ETF1,994US$340KJun 30, 2026
JPMorgan Global Allocation Fund1,600US$258KJul 31, 2026
Emerging Markets Social Core Equity Portfolio1,576US$254KJul 31, 2026
Emerging Markets ex China Core Equity Portfolio1,509US$243KJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio1,496US$241KJul 31, 2026
BlackRock Balanced Fund, Inc.1,468US$242KMay 29, 2026
World ex U.S. Core Equity Portfolio1,373US$221KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio1,296US$221KJun 30, 2026
Diversified Equity Alpha Master Portfolio1,283US$220KJun 30, 2026
iShares MSCI Emerging Markets Small-Cap ETF1,258US$207KMay 31, 2026
Vanguard ESG International Stock ETF981US$162KMay 31, 2026
Polen Emerging Markets Growth Fund879US$151KApr 30, 2026
MFS Emerging Markets Equity Portfolio786US$134KJun 30, 2026
JNL/JPMorgan Global Allocation Fund784US$126KMar 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF697US$114KJul 31, 2026
Parametric Emerging Markets Fund653US$105KJul 31, 2026
TSW Emerging Markets Fund500US$85,200Jun 30, 2026
BlackRock Balanced Portfolio449US$76,940Jun 30, 2026

This page holds 50 of 61 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carrie StromChief Executive Officer · Since at least Oct 13, 2025

Open People

Log in to ask 6ix AI your own questions about Hugel, Inc.